Loading clinical trials...

Immunogenicity of Cholera Vaccine in Children With IBD | Clinical Trials | Clareo Health

COMPLETEDNA

Immunogenicity of Cholera Vaccine in Children With IBD

Evaluation of Immunogenicity of Cholera Vaccine in Children With Inflammatory Bowel Disease

NCT03998449•Medical University of Warsaw

Summary

Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.

Eligibility

Age

6 - 18 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•diagnosis of Crohn's disease or ulcerative colitis based on standard clinical, endoscopic, histologic and radiographic criteria (Porto criteria),
•no vaccination against cholera in the past,
•written consent of the patient's legal guardians and the patient himself if he/she turns 16 years of age.

Exclusion Criteria

•serious exacerbation of inflammatory bowel disease defined as Paediatric Ulcerative Colitis Activity Index (PUCAI) \> 65 points for patients with ulcerative colitis or Pediatric Crohn's Disease Activity Index (PCDAI) \> 40 points for patients with Crohn's disease.

Locations (1)

Medical University of Warsaw

Warsaw, Poland

Key Dates

Start Date

August 30, 2017

Primary Completion Date

April 1, 2020

Completion Date

May 1, 2020

Last Updated

May 20, 2020

Enrollment

ACTUAL participants

Conditions

CholeraInflammatory Bowel Diseases

Interventions

Vaccination against cholera

BIOLOGICAL

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITING

Institutional Registry of Rare Diseases

NCT06573723

Rare DiseasesAmyloidosis+24 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Immunogenicity of Cholera Vaccine in Children With IBD

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Institutional Registry of Rare Diseases

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)

Therapeutic Endpoint in Pediatric IBD Conditions